MiR-431 Inhibits Adipogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells Via Targeting Insulin Receptor Substance 2
Overview
Authors
Affiliations
Background: An understanding of the mechanism underlying adipogenic differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs) will provide new therapeutic approaches for many diseases, including osteoporosis. This study aimed to investigate the role of miR-431 in adipogenic differentiation of hMSCs.
Methods: hMSCs were induced for adipogenic differentiation and miR-431 was detected by polymerase chain reaction (PCR). hMSCs were transfected by miR-431 or small interfering RNA (siRNA) for insulin receptor substance 2 (IRS2). The expression of IRS2 was detected by PCR and Western blot analysis. The targeting of the 3'-untranslated region (UTR) of IRS2 by miR-431 was examined by luciferase assay.
Results: miR-431 expression was decreased during adipogenesis of hMSCs. Overexpression of miR-431 inhibited adipogenic differentiation, accompanied by the downregulation of CCAAT/enhancer binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ), two key regulators of adipogenesis. Moreover, miR-431 decreased both protein and mRNA levels of IRS2. The expression of IRS2 was increased during adipogenic differentiation of hMSCs in conjunction with decreased levels of miR-431, and knockdown of IRS2 in hMSCs inhibited adipogenic differentiation. Luciferase assay confirmed that miR-431 targeted the 3'-UTR of IRS2 in hMSCs.
Conclusions: This is the first study to show that miR-431 inhibits adipogenic differentiation of hMSCs via targeting IRS2.
Xu H, Luo Y, Zhang M, Pan C, Lan X, Zheng J Animals (Basel). 2025; 14(24.
PMID: 39765535 PMC: 11672851. DOI: 10.3390/ani14243631.
Redling D, Bialak S, El Ghormli L, Chernausek S, Jones K, Tryggestad J J Clin Endocrinol Metab. 2024; 109(12):3027-3035.
PMID: 38815053 PMC: 11570374. DOI: 10.1210/clinem/dgae376.
Jankowski M, Farzaneh M, Ghaedrahmati F, Shirvaliloo M, Moalemnia A, Kulus M Cells. 2023; 12(21).
PMID: 37947637 PMC: 10649218. DOI: 10.3390/cells12212559.
Small interfering RNAs in the management of human osteoporosis.
Gargano G, Asparago G, Spiezia F, Oliva F, Maffulli N Br Med Bull. 2023; 148(1):58-69.
PMID: 37675799 PMC: 10788844. DOI: 10.1093/bmb/ldad023.
miR-33a Inhibits the Differentiation of Bovine Preadipocytes through the IRS2-Akt Pathway.
Zhang W, Raza S, Li B, Sun B, Wang S, Pant S Genes (Basel). 2023; 14(2).
PMID: 36833456 PMC: 9957011. DOI: 10.3390/genes14020529.